An interventional study of Building Lifestyle Options for Orthopedic Mobility (BLOOM) in Obesity, Knee Osteoarthritis and Hip Osteoarthritis, sponsored by Ottawa Hospital Research Institute. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-22.
Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to prospectively assess the efficacy of the BLOOM program, a comprehensive weight loss dietary and lifestyle program, in a population of patients living with obesity and awaiting hip or knee surgery. The main questions it seeks to answer are:
Study participants will undergo the BLOOM program, a virtual pre-operative weight management program that spans 24 weeks and is carefully supervised by medical professionals. They will be recruited at the LEAF Clinic after being referred by their primary care physician.
During the BLOOM program, they will meet with a physician (initially, then once monthly) and a dietitian (initially, and then biweekly as part of virtual group coaching). They will have access to LEAF's online learning portal. These are normal elements of the BLOOM program.
Furthermore, as part of their participation in the research study, participants will be asked to complete the following questionnaires: the Mediterranean dietary score, the Oxford Hip and Knee Questionnaire and the EQ-D5-5L quality of life assessment. They will complete these initially, and then at completion of the program and 3 and 6 months post-program. We will also collect their height and weight at these intervals.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 58 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Ottawa Hospital Research Institute is the lead sponsor of 547 studies on the registry; 99 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
To be eligible for the study, subjects must meet all the following criteria:
Exclusion Criteria:
Subjects who meet any of the following criteria are not eligible for the study:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All study participants will be assigned to the intervention arm of this trial where they will undergo the BLOOM lifestyle program for weight loss. This program is 24 weeks in duration and includes group nutrition coaching with a dietitian, regular physician appointments and access to online support materials. Participants may also choose to pursue weight loss medication or meal replacement therapy, although this is not specifically part of the BLOOM program being studied.
Behavioral: Building Lifestyle Options for Orthopedic Mobility (BLOOM)
This intervention is a lifestyle program with includes dietary coaching from a dietitian and regular doctor appointments with a bariatric medicine specialist over the course of 24 weeks.
Weight loss
The difference (in lbs and %) in weight between the admission visit and the end of the BLOOM program
Time frame: Weight will be compared from beginning of program to end of program, six months after program completion, and also monthly for months 1-5.
Weight - BMI 35-40
The difference (in lbs and %) in weight between the admission visit and the end of the BLOOM program for individuals with a BMI of 35-39.9
Time frame: Six months
Weight - BMI 40+
The difference (in lbs and %) in weight between the admission visit and the end of the BLOOM program for individuals with a BMI over 40
Time frame: Six months
Mediterranean Diet Score
The change in the Mediterranean Dietary Score between the initial visit and the end of the BLOOM program and 3 and 6 months after
Time frame: At program start, at program completion (approx 6 months, 3 and 6 months post-program completion (total time: twelve months)
Oxford Knee and Hip
The change in the Oxford Hip and Knee Questionnaires between the initial visit and the end of the BLOOM program and three and six months after.
Time frame: At program start, at program completion (approx 6 months, 3 and 6 months post-program completion (total time: twelve months)
EQ-5D-5L
The change in the EQ-5D-5L quality of life (QoL) score between the initial visit and the end of the BLOOM program and three and six months after.
Time frame: At program start, at program completion (approx 6 months, 3 and 6 months post-program completion (total time: twelve months)
Decision change
The proportion of patients that have a change of decision for joint arthropathy.
Time frame: Twelve months
Weight change
The proportion of patients who continued to lose weight or maintained their weight 3 and 6 months after the end of the program
Time frame: Twelve months
No study locations are listed for this record.
Plan to share: No — There is currently no plan to share IPD with other researchers, nor are we seeking institutional ethical approval for such sharing.
No publications or documents are linked to this record.
Start is estimated for Dec 2023; primary completion for Dec 2024, 12 months later.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ottawa Hospital Research Institute →